Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms

• Status: Completed
• Trial end date: 2006-03-01
• Target enrollment: 0
• Participant gender: All

Summary

32 outpatients with a Posttraumatic Stress Disorder were included in a randomized comparative single-blind study to study the efficacy of aripiprazole to treat post-traumatic stress symptoms.

The hypothesis is that aripiprazole has an efficacy to reduce PTSD symptoms

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Federal University of São Paulo
• Treatments: Aripiprazole

Criteria

Inclusion Criteria:

• Clinical diagnosis of PTSD (after SCID-I application by a trained psychiatrist).

• Use of an effective contraceptive method when the subject is women with sexual activity and with risk of pregnancy.

Exclusion Criteria:

• Clinical diagnosis of schizophrenic, delusional, psychotic depression, schizoaffective, bipolar or borderline personality (after SCID-I application by the a trained psychiatrist).

• Clinical diagnosis of psychoactive substance dependence within 6-months before the study enrollment.

• To have decompensated medical diagnostics needing urgent treatment

• being pregnant.

• using psychoactive drugs.